Clinical Trials Logo

Filter by:
NCT ID: NCT02258464 Terminated - Breast Neoplasms Clinical Trials

Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer

Start date: March 2, 2015
Phase: Phase 2
Study type: Interventional

The objective of this study was to assess efficacy and safety of radium-223 dichloride in subjects with human epidermal growth factor receptor 2 negative (HER2 negative) hormone receptor positive breast cancer with bone metastases treated with hormonal treatment background therapy

NCT ID: NCT02258022 Terminated - Sepsis Clinical Trials

Changes in 13CO2/12CO2 Delta Value in Exhaled Breath as an Early Indicator of Infection in Adult Trauma Subjects

Start date: October 2014
Phase: N/A
Study type: Interventional

Carbon-12 and carbon-13 are naturally-abundant isotopes in exhaled breath carbon dioxide. The ratio of carbon-13 to carbon-12 in exhaled breath is known as the breath delta value. This study is seeking to determine if the breath delta value of adults with trauma is an early indicator of the onset of infection that may lead to sepsis.

NCT ID: NCT02257684 Terminated - Clinical trials for Acute Lymphoblastic Leukemia

A Dose Confirmation and Pharmacokinetic Study of Pegcrisantaspase Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Lymphoblastic Leukemia (ALL) /Lymphoblastic Lymphoma (LBL). Following Hypersensitivity to Pegaspargase (Oncaspar)

Start date: September 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effectiveness,safety, and dosage of pegcrisantaspase in patients with Acute Lymphoblastic Leukemia (ALL) / Lymphoblastic Lymphoma (LBL).

NCT ID: NCT02257619 Terminated - Clinical trials for NSCLC (Non-small Cell Lung Carcinoma)

Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer

Start date: September 2014
Phase: Phase 2
Study type: Interventional

The primary objectives of this study is to evaluate the safety and tolerability of itacitinib in combination with docetaxel and to select doses for further evaluation (Part 1, safety run-in portion).

NCT ID: NCT02257307 Terminated - Clinical trials for Retinopathy of Prematurity

Telemedicine Approaches to Evaluating Acute-Phase ROP eROP Implementation Project

Start date: July 2014
Phase: N/A
Study type: Observational

Evaluating retinopathy of prematurity (eROP) ancillary study Implementation Project is a multi-center observational study will focus on feasibility, and relative cost-effectiveness of an retinopathy of prematurity (ROP) telemedicine evaluation system to detect eyes of at-risk babies and provide timely feedback to the examining ophthalmologist at the Clinical Center.

NCT ID: NCT02256982 Terminated - Clinical trials for Unresectable Intrahepatic Cholangiocarcinoma

A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma

Start date: October 2014
Phase: N/A
Study type: Interventional

This research study is evaluating the use of radiation therapy in combination with chemotherapy as a possible treatment for intrahepatic cholangiocarcinoma, a rare form of gastrointestinal cancer.

NCT ID: NCT02256007 Terminated - Stroke Clinical Trials

Cognitive Motor Therapy Applications Using Videogame Platform

Start date: September 2014
Phase: N/A
Study type: Interventional

This study designs and develops an evidence-based game approach that will enhance the investigators understanding and usability of electronic tools to measure cognitive and sensorimotor abilities in an inpatient rehabilitation stroke population.

NCT ID: NCT02255968 Terminated - Healthy Clinical Trials

Evaluation of the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of EDP-788

Start date: August 2014
Phase: Phase 1
Study type: Interventional

The primary objective of the study is to determine the safety and tolerability of multiple doses of orally administered EDP-788. Secondary objectives of the study are to describe the pharmacokinetics of EDP-788 (and its metabolite EDP-322) after multiple doses of orally administered drug.

NCT ID: NCT02255838 Terminated - Pneumonia Clinical Trials

Evaluation of a Disposable Flexible Bronchoscope, aScope IV

EVAL
Start date: April 1, 2015
Phase: N/A
Study type: Interventional

Flexible bronchoscopes are typically reusable and therefore need high level disinfection to prevent inadvertent spread of microbial pathogens from patient to patient. The process of disinfection is time consuming and expensive. Moreover, a bronchoscope being processed may not be readily available for another patient. One solution to this problem was to use a single use disposable sheath that covers a flexible bronchoscope protecting all surfaces of the bronchoscope.(Colt, Beamis, Harrell, & Mathur, 2000). Another way to eliminate potential hazards with a reusable bronchoscope is the use of a disposable bronchoscope. Such a disposable bronchoscope has been developed (Ambu aScope, Ambu, Glen Burnie, MD) and has been used successfully for intubations in manikins(Scutt et al., 2011) and patients. (Kristensen & Fredensborg, 2013; Pujol, López, & Valero, 2010; Tvede, Kristensen, & Nyhus-Andreasen, 2012). Further advancement in the imaging and handling of this disposable flexible bronchoscope now allows for the purpose of bronchoscopy and broncho-alveolar lavage in critically ill patients with pulmonary compromise. (FDA approval: 05-11-2013 date) The aim of the study is to compare image clarity, suction capacity, and handling performance of a reusable flexible bronchoscope to the disposable flexible bronchoscope. In addition, the investigators intend to perform a cost analysis.

NCT ID: NCT02255487 Terminated - Clinical trials for Surgical Site Infection

Irrisept Versus Standard of Care in the Prevention of Surgical Site Infections

Start date: February 18, 2015
Phase: N/A
Study type: Interventional

The purpose of this study was to compare the rate of surgical site infections in patients randomized to Irrisept versus SoC, who had an open abdominal laparotomy for abdominal trauma or acute surgical abdomen.